![](https://thehcdata.com/wp-content/uploads/2023/10/pexels-lumn-327882.webp)
Baxter International Inc. (NYSE:BAX), a global innovator in kidney care and vital organ support, announced today new data indicating Baxter’s Sharesource remote patient management (RPM) digital platform, when used with an automated peritoneal dialysis (PD) system, is associated with a 77% reduction in risk of PD technique failure. Technique failure can be due to several factors and results in PD patients being switched to in-center dialysis. Additional key data show HDx therapy enabled by Theranova dialyzer provides expanded hemodialysis therapy, which can help reduce annual water consumption by 27% and annual electricity usage by 17%, and associated costs, in comparison with online HDF (hemodiafiltration).
The highlighted data was presented at ASN: Kidney Week, November 2-5, in Philadelphia, Pa., from abstracts—“Role of Remote Monitoring in Automated Peritoneal Dialysis: Impact in SONG-PD (Standardized Outcomes in Nephrology-Peritoneal Dialysis) and Results from RPM-APD Multicenter Study” [#SA-PO654] and “Comparison of Utilities Consumption Between Different Modalities of In-Center Haemodialysis” [#TH-PO291]—and were part of 17 scientific exchanges supported by Baxter during the conference.
“These new data help us further understand the essential role digital capabilities play in helping kidney patients stay on home dialysis longer, and the potential to support more sustainable care options,” said Professor Peter Rutherford, MB BS, PhD., head of global medical affairs, Kidney Care, Baxter. “Supporting continued research on proven technologies helps the collective efforts of industry, healthcare providers and policymakers better understand how to make meaningful advances toward increasing access to and improvements in the care we provide.”
Source link : https://www.baxter.com/